Amy Paller
Northwestern University · Lurie Children's Hospital/Northwestern University · Department of Dermatology, Chair
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Amy Paller as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:25 UTC. Open this list on ClinicalTrials.gov
- Early Ph1NCT07813533 · A Pilot Study to Examine the Efficacy and Tolerability of Sirolimus on Epidermal Nevi Lesions in Patients 6 Years Old and Above.Northwestern University · not yet recruiting · Epidermal Nevi · principal investigator
- Early Ph1NCT07050810 · Thera-Clean® Microbubbles System in Patients With Skin DiseasesNorthwestern University · enrolling by invitation · Epidermolysis Bullosa, Ichthyosis, Atopic Dermatitis · principal investigator
- Ph1/Ph2NCT06545695 · Epidermal Growth Factor Receptor Inhibition for KeratinopathiesNorthwestern University · not yet recruiting · Epidermolytic Ichthyosis, Palmoplantar Keratoderma, Pachyonychia Congenita · principal investigator
- Early Ph1NCT05649098 · Repurposing Dupilumab for Management of Pruritic Genetic Inflammatory Skin DisordersNorthwestern University · recruiting · Skin Diseases · principal investigator
- Ph3NCT05180708 · A Multicenter, Phase 3 Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy of QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Pachyonychia CongenitaPalvella Therapeutics, Inc. · completed · Pachyonychia Congenita · study chair
- Ph4NCT05042258 · Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic DermatitisNorthwestern University · recruiting · Atopic Dermatitis, Sleep Disturbance · principal investigator
- N/ANCT04630821 · Utilizing Topical Sodium Hypochlorite to Ameliorate Radiation DermatitisNorthwestern University · terminated · Radiation Dermatitis · principal investigator
- Early Ph1NCT04549792 · An Open-Label and Long-Term Extension Study to Evaluate the Efficacy and Safety of Ustekinumab in the Treatment of Patients With IchthyosesNorthwestern University · completed · Ichthyosis · principal investigator
- N/ANCT04486742 · Brief Cognitive Behavioral Therapy to Treat Itch Rumination "Itch CBT" in EczemaNorthwestern University · completed · Atopic Dermatitis · principal investigator
- Ph3NCT03927716 · A Phase 3 Randomized Parallel Group Study Comparing the Efficacy & Safety of SB206 & Vehicle Gel in the Treatment of MC (B-SIMPLE1)Novan, Inc. · completed · Molluscum Contagiosum · principal investigator
- N/ANCT03791216 · Characterization of Lipoprotein Composition and Function in Pediatric Psoriasis Before and After TreatmentNorthwestern University · completed · Psoriasis · principal investigator
- N/ANCT03768284 · Genetic Analysis of Pediatric PsoriasisNorthwestern University · completed · Psoriasis · principal investigator
- N/ANCT03544866 · The Impact of Pediatric Skin Disorders: The "Big" StudyNorthwestern University · completed · Chronic Pediatric Skin Conditions · principal investigator
- N/ANCT03051347 · Asthma and Atopic Dermatitis Validation of PROMIS Pediatric InstrumentsNorthwestern University · completed · Atopic Dermatitis, Ichthyosis, Psoriasis · principal investigator
- Ph2NCT03041038 · The Efficacy and Safety of Secukinumab in Patients With IchthyosesNorthwestern University · completed · Ichthyosis, Autosomal Recessive Congenital Ichthyosis, Lamellar Ichthyosis · principal investigator
- N/ANCT02865070 · A Smart, "Always -On" Health Monitoring SystemNorthwestern University · completed · Premature Birth · principal investigator
- N/ANCT02299206 · CeraVe Cream Compared to Desitin Paste for Treating Diaper Dermatitis in InfantsNorthwestern University · terminated · Diaper Rash · principal investigator
- N/ANCT01782703 · Defining the Skin and Blood Biomarkers of Pediatric Atopic DermatitisNorthwestern University · active not recruiting · Atopic Dermatitis, Eczema · principal investigator
- N/ANCT01216059 · Text Messaging and Atopic DermatitisNorthwestern University · completed · Atopic Dermatitis · principal investigator
- N/ANCT00848744 · Comparison of Two Salicylic Acid FormulationsNorthwestern University · completed · Acne Vulgaris · principal investigator
- N/ANCT00787943 · Study of Two Different 10.0% Benzoyl Peroxide Creams for Mild to Moderate Acne VulgarisNorthwestern University · completed · Acne Vulgaris · principal investigator
- N/ANCT00558831 · Study of Benzoyl Peroxide Cream for Mild to Moderate Acne VulgarisNorthwestern University · completed · Acne Vulgaris · principal investigator
- Ph4NCT00179959 · The Impact of Treating Staphylococcus Aureus Infection and Colonization on the Clinical Severity of Atopic DermatitisNorthwestern University · completed · Atopic Dermatitis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:25 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Consortium for Hereditary Epidermal Differentiation Disorders (CHEDD)U54AR089183 · NIAMS · NORTHWESTERN UNIVERSITY · fiscal years 2026 · $1,600,000 awarded in 2026Same name and institution; not confirmed by an ID
- Northwestern University Skin Biology and Diseases Resource-based CenterP30AR075049 · NIAMS · NORTHWESTERN UNIVERSITY · fiscal years 2019 to 2026 · $710,832 awarded in 2026Same name and institution; not confirmed by an ID
- Post Graduate Program in Cutaneous BiologyT32AR060710 · NIAMS · NORTHWESTERN UNIVERSITY · fiscal years 2024 to 2026 · $161,870 awarded in 2026Same name and institution; not confirmed by an ID
- Neuron-Keratinocyte Communication in the Epidermis in Normal and Diabetic Wound HealingR01AR077691 · NIAMS · NORTHWESTERN UNIVERSITY · fiscal years 2020 to 2023 · $668,797 awarded in 2023Same name and institution; not confirmed by an ID
- Glycosphingolipids Mediate Diabetic Wound Healing ImpairmentR01AR068375 · NIAMS · NORTHWESTERN UNIVERSITY · fiscal years 2016 to 2020 · $403,103 awarded in 2020Same name and institution; not confirmed by an ID
- Administrative CoreP30AR057216 · NIAMS · NORTHWESTERN UNIVERSITY · fiscal years 2009 to 2018 · $212,714 awarded in 2018Same name and institution; not confirmed by an ID
- Atopic Dermatitis Validation of PROMIS Pediatric InstrumentsU19AR069526 · NIAMS · NORTHWESTERN UNIVERSITY · fiscal years 2015 · $756,296 awarded in 2015Same name and institution; not confirmed by an ID
- Topical Delivery of siRNA Nanconjugates: Suppressing Epidermal HyperplasiaR01AR060810 · NIAMS · NORTHWESTERN UNIVERSITY · fiscal years 2012 to 2015 · $342,174 awarded in 2015Same name and institution; not confirmed by an ID
- siRNA-gold nanoparticle mediated ganglioside depletion for diabetic wound healingR21AR062898 · NIAMS · NORTHWESTERN UNIVERSITY · fiscal years 2012 to 2013 · $190,401 awarded in 2013Same name and institution; not confirmed by an ID
- Ganglioside Gene Modulation Effect on Cell MotilityR01AR044619 · NIAMS · NORTHWESTERN UNIVERSITY · fiscal years 1998 to 2007 · $310,660 awarded in 2007Same name and institution; not confirmed by an ID
- GANGLIOSIDES AND EPIDERMAL GROWTH AND DIFFERENTIATIONK08AR001811 · NIAMS · LURIE CHILDREN'S HOSPITAL OF CHICAGO · fiscal years 1990 to 1994 · $73,440 awarded in 1994Same name and institution; not confirmed by an ID
- GANGLIOSIDES & EPIDERMAL GROWTH & DIFFERENTIATIONS07RR005370 · NCRR · NORTHWESTERN UNIVERSITY · fiscal years 1991Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:25 UTC. The ranking covers the 200 most relevant of 88 PubMed records, and a shared surname and initials can bring in a namesake. All 88 on PubMed
- 476 citationsRCR 33.7
- Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults.J Am Acad Dermatol · 2016421 citationsRCR 19.4
- Efficacy and Safety of Dupilumab in Adolescents With Uncontrolled Moderate to Severe Atopic Dermatitis: A Phase 3 Randomized Clinical Trial.JAMA Dermatol · 2020421 citationsRCR 27.1
- Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity.Pediatrics · 2009340 citationsRCR 11.1
- Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial.J Am Acad Dermatol · 2020309 citationsRCR 20.3
- Etanercept treatment for children and adolescents with plaque psoriasis.N Engl J Med · 2008293 citationsRCR 9.7
- Efficacy and Safety of Lebrikizumab, a High-Affinity Interleukin 13 Inhibitor, in Adults With Moderate to Severe Atopic Dermatitis: A Phase 2b Randomized Clinical Trial.JAMA Dermatol · 2020278 citationsRCR 16.2
- 237 citationsRCR 23.1
- A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients.J Am Acad Dermatol · 2001217 citationsRCR 7.5
- Ustekinumab in adolescent patients age 12 to 17 years with moderate-to-severe plaque psoriasis: results of the randomized phase 3 CADMUS study.J Am Acad Dermatol · 2015173 citationsRCR 7.9